CanCertain

Curated by Signal

Developer of personalized tests to detect cancer for precision medicines

Overview

Developer of personalized tests to detect cancer for precision medicines. The company uses 3D cell culture techniques to identify the most effective treatment for each cancer patient. The products include liquid-biopsy-based drug testing and immunotherapies testing.

Key facts

Founded: 2017
Headquarters: Runcorn, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

5 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Automata
Provider of lab automation robots
Life Sciences TechnologyLondon, United Kingdom
FreeStyle Diabetes
Manufacturer of on-demand and continuous blood glucose monitors
Life Sciences TechnologyLondon, United Kingdom
Palarum
Provider of eTextile wearable technology for patients
Life Sciences TechnologyLondon, United Kingdom

About CanCertain

What does CanCertain do?

Developer of personalized tests to detect cancer for precision medicines.

Where is CanCertain headquartered?

CanCertain is headquartered in Runcorn, United Kingdom.

When was CanCertain founded?

CanCertain was founded in 2017.

Which sector is CanCertain in?

CanCertain operates in Life Sciences Technology.

Who are CanCertain's competitors?

Companies similar to CanCertain include Automata, FreeStyle Diabetes, and Palarum.